NCT01450514View on ClinicalTrials.gov

POC Study of Pipamperone Added to Stable Treatment With RIS or PAL in Chronic Schizophrenia

PHASE2CompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

November 30, 2012

Study Completion Date

December 31, 2012

Conditions
Chronic SchizophreniaSchizoaffective Disorder
Interventions
DRUG

Pipamperone

15 mg PIP once daily per os on top of continued stable treatment with RIS or PAL

DRUG

Placebo

matching placebo sugar pill once daily per os on top of continued stable treatment with RIS or PAL

Trial Locations (1)

Unknown

University Psychiatric Institute Sint-Jozef, Kortenberg

All Listed Sponsors
lead

PharmaNeuroBoost N.V.

INDUSTRY

NCT01450514 - POC Study of Pipamperone Added to Stable Treatment With RIS or PAL in Chronic Schizophrenia | Biotech Hunter | Biotech Hunter